About
AmnioChor is a biotech company based in perinatal stem cell technology. The Company has identified a source and method of acquiring and preserving human stem cells. AmnioChor’s stem cells will allow a tremendous expansion of the private stem cell storage industry and stem cell based therapies to augment the cord blood banking industry. The Mesenchymal and Epithelial stem cells that reside in the amnion placental tissue, are readily available in pristine quality at childbirth. AmnioChor has developed the technology to capture and cryopreserve the placental tissue, and will build a new tissue bank. AmnioChor’s new OMNIBANK is a long term vision based on the significant future value of these Amnion Derived Stem Cells (ADSCs), for regenerative medicine, and the creation of new stem cell based therapies, i.e. the future of Healthcare.